Who Are We?
Welcome to the Canadian Pharmaceutical Manufacturers and Exporters Alliance (CPMEA), a trade alliance representing pharmaceutical companies that proudly manufacture in Canada. The CPMEA is a collaborative force committed to cultivating a strong domestic drug manufacturing sector and a resilient pharmaceutical supply chain in Canada.
Our members have united to tell the story about the economic impact and contribution of Canadian medicine producers, as well as the unique challenges we face. Our vision is to work with stakeholders to make Canada the very best country in the world for manufacturing medicines. CPMEA invites you to explore our initiatives and participate in shaping the future of pharmaceutical manufacturing in Canada.
80
"OVER
%
of the activities required to make the drugs sold in Canada are conducted in other countries…and the growing consolidation of global supply chains increases the likelihood of more shortages."
HEALTH CANADA
According to Statistics Canada, Canadian companies manufacture almost
$
13
BILLION
Canadians, and export more than
of pharmaceutical products, employ more than
$
9
BILLION
33
,000
in Canadian-made medicines to the U.S.
Who Are We?
The Canadian Pharmaceutical Manufacturers and Exporters Alliance (“CPMEA”), is an emerging trade alliance representing pharmaceutical companies that proudly manufacture in Canada. Founded by industry leaders Apotex, Laboratoire Riva, and Pharmascience, CPMEA is a collaborative force committed to advocating for Canadian pharmaceutical producers, cultivating a robust domestic manufacturing sector, and steering discussions towards a resilient pharmaceutical landscape in Canada.
With a long-term vision to enhance Canada’s healthcare system and foster economic growth, CPMEA invites you to explore our initiatives and participate in shaping the future of biomanufacturing in Canada.
OUR VALUES
CANADA FIRST
Canadian pharmaceutical producers play a crucial role in providing a dependable supply of medicines for Canadians, reducing our reliance on foreign sources, and averting shortages. This commitment ensures that Canadians have access to top-quality medicines that meet the highest standards manufactured locally in Canada. Domestic manufacturing capacity is a vital public health asset and a valuable national economic resource.
OUR VALUES
ACCESS
We are committed to ensuring access to essential medicines for all Canadians. Canadian domestic pharmaceutical manufacturers strive to reduce barriers to access, ultimately improving healthcare outcomes and quality of life for all Canadians. Our goal is to ensure that every patient has equitable and affordable access to the medications they need.
OUR VALUES
TRUST
Trust is at the core of everything we do. Canadian pharmaceutical producers are respected worldwide for supply reliability, product safety, and rigorous compliance with the highest global standards in pharmaceutical manufacturing. Our commitment to providing the best quality medications is unwavering. You can trust that Canada’s drug producers will be there to ensure availability, security, and quality.
OUR VALUES
ECONOMIC SUSTAINABILITY
The Canadian pharmaceutical manufacturing industry is confronting a sustainability crisis. facing challenges due to competition from global players in low-wage countries, while costs have escalated due to inflation, higher wages, and changing regulatory obligations. The COVID-19 pandemic underscored the vulnerability of our medical supply chain, highlighting the essential nature of local production, too. A strong domestic pharmaceutical manufacturing sector is critical and represents the opportunity to achieve broad-based economic gains, as well as public health security. We call on all levels of government to make Canadian pharmaceutical manufacturing a priority, recognizing its critical role in safeguarding the sovereignty of Canada’s medicines supply.
Canada is heavily reliant on imported medicines at a time of increasing national security concerns and geopolitical uncertainty. Action to ensure the sovereignty of our medicine supply and balance risk with a healthy manufacturing environment just makes good sense.
of the activities required to make the drugs sold in Canada are conducted in other countries…and the growing consolidation of global supply chains increases the likelihood of more shortages."
"OVER 80%
HEALTH CANADA
Canadians, and export more than
According to Statistics Canada, Canadian companies manufacture almost
of pharmaceutical products, employ more than
in Canadian-made medicines to the U.S.
